Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Timothy M. Pabst"'
Autor:
Haibin Luo, Qun Du, Chen Qian, Michelle Mlynarczyk, Timothy M. Pabst, Melissa Damschroder, Alan K. Hunter, William K. Wang
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Journal of chromatography. A. 1655
The adsorption kinetics of a monoclonal antibody (mAb) used as a reference and of bivalent bispecific antibodies (BiSAb) on a macroporous cation exchanger is studied experimentally by examining the transient patterns of bound protein within the parti
Publikováno v:
Journal of Chromatography A. 1601:121-132
The cation exchange chromatographic behavior of three homologous bivalent bispecific antibodies (BiSAb) is characterized for two different resins, Source 15S and ProPac WCX-10, having different base matrix, particle size, pore structure, and ligand c
Publikováno v:
Journal of Chromatography A. 1601:133-144
In Part I of this work we determined the experimental cation exchange behavior of bivalent bispecific antibodies (BiSAb) comprising a pair of single chain variable fragment (scFv) domains flexibly linked to a framework immunoglobulin G (IgG), which e
Publikováno v:
mAbs. 11:789-802
We report a case study in which liquid-liquid phase separation (LLPS) negatively impacted the downstream manufacturability of a therapeutic mAb. Process parameter optimization partially mitigated the LLPS, but limitations remained for large-scale man
Autor:
Haibin, Luo, Qun, Du, Chen, Qian, Michelle, Mlynarczyk, Timothy M, Pabst, Melissa, Damschroder, Alan K, Hunter, William K, Wang
Publikováno v:
Journal of Chromatography A. 1679:463385
Protein A chromatography with a high salt wash usually leads to robust clearance of host cell proteins (HCPs) in most recombinant monoclonal antibodies (mAbs), but a small subset of recalcitrant mAbs show significant HCP copurification. In this study
Autor:
Timothy M. Pabst, Haibin Luo, Sheau‐Chiann Wang, Guoling Xi, William K. Wang, David Robbins, Yuling Li, Chenghong Wei, Matthew Cox, Simone M. Nicholson
Publikováno v:
Biotechnology Progress
Process‐related impurities (PRIs) derived from manufacturing process should be minimized in final drug product. ICH Q3A provides a regulatory road map for PRIs but excludes biologic drugs like monoclonal antibodies (mAbs) that contain biological PR
Autor:
null Haibin Luo, null Yuling Li, null David Robbins, null Sheau‐Chiann Wang, null Guoling Xi, null Matthew Cox, null Simone M. Nicholson, null Chenghong Wei, null Timothy M. Pabst, null William K. Wang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd41b36bca4080eb82991be419b93f6b
https://doi.org/10.1002/btpr.3119/v2/response1
https://doi.org/10.1002/btpr.3119/v2/response1
Publikováno v:
Journal of Chromatography A. 1648:462181
The elution and adsorptive behavior of a bivalent bispecific antibody (BiSAb), comprising an IgG1 framework with a scFv domain genetically fused to each heavy chain C-terminus via flexible linkers, and of two associated fragments were studied on two
Publikováno v:
Journal of Chromatography A. 1617:460836
The elution behavior of bivalent bispecific antibodies (BiSAb) comprising an immunoglobulin G framework genetically fused to a pair of single chain variable fragments (scFvs) was studied on hydrophobic interaction chromatography (HIC) columns using a